drugset
drugset / Trial / NCT06643507

Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions

NCT06643507 ↗

Phase 2/3 Recruiting 26 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

treatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF

Timeline

Start
2025-04-20
Primary completion
2026-12-20
Completion
2027-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ALB-PRF Unknown — —

Indications

gingival recession